EnWave Signs Technology License and Joint Development Agreement with GEA Lyophil GmbH to Advance REV™ Technology for Pharmaceutical Applications
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave,” or the "Company” – https://www.commodity-tv.com/play/enwave-moon-cheese-highly-profitable-selling-more-rev-machines-in-2019/ ) today announced signing a technology license and joint development agreement (the “JDA”) with GEA Lyophil GmbH (“GEA Lyophil”), a global manufacturer and marketer of freeze-dry units for the Mehr

